Form 4: Precision BioSciences Executive J. Jefferson Smith Acquires Restricted Stock Units
SEC Form 4 Filing
J. Jefferson Smith, Chief Research Officer of Precision BioSciences, acquired 31,343 restricted stock units on April 18, 2024, according to a Form 4 filing.
Summary
- On April 18, 2024, J. Jefferson Smith, the Chief Research Officer of Precision BioSciences, acquired 31,343 restricted stock units (RSUs).
- Each RSU represents a contingent right to receive one share of Precision BioSciences' common stock.
- The RSUs vest in three substantially equal annual installments starting on January 20, 2025, contingent upon Smith's continued service to the company.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to executive compensation, and does not contain information that would significantly impact sentiment positively or negatively.
Positives
- The vesting schedule incentivizes continued service by the Chief Research Officer.
Future Outlook
The document does not contain any specific forward-looking statements regarding the company's future performance, but the vesting schedule of the RSUs suggests an expectation of continued service from the Chief Research Officer.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates compensation for a key executive.
Stakeholder Impact
- Shareholders may view the granting of RSUs as a way to align management's interests with the company's long-term success.
- Employees may see this as a positive sign of investment in key personnel.
Key Dates
| Date | Description |
|---|---|
| 04/18/2024 | Date of transaction: J. Jefferson Smith acquired restricted stock units. |
| 01/20/2025 | First vesting date for the restricted stock units. |
| 04/22/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.